US 10029987
Therapeutic compounds and compositions
granted A61KA61K31/497A61K31/5513
Quick answer
US patent 10029987 (Therapeutic compounds and compositions) held by Agios Pharmaceuticals, Inc. expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/497, A61K31/5513, A61P, A61P35/00